object
data
avail
inflight
transmiss
report
inflight
transmiss
cluster
describ
clinic
characterist
patient
method
flight
laboratoryconfirm
report
patient
ten
patient
admit
design
hospit
data
collect
th
januari
th
februari
clinic
inform
retrospect
collect
result
patient
passeng
without
flight
attend
median
age
year
femal
none
admit
intens
care
unit
patient
succumb
th
februari
median
incub
period
day
ill
onset
hospit
admiss
day
common
symptom
fever
two
patient
asymptomat
neg
chest
ct
scan
throughout
diseas
cours
admiss
initi
rtpcr
posit
patient
howev
initi
chest
ct
posit
half
patient
median
lung
total
sever
score
chest
ct
notabl
crazypav
pattern
pleural
effus
groundglass
nodul
also
seen
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
case
report
rapid
increas
expect
continu
time
spread
rapidli
around
world
larg
person
infect
travel
aircraft
countri
sinc
strong
affin
human
respiratori
receptor
data
avail
risk
transmiss
aircraft
clinic
characterist
outcom
patient
conduct
retrospect
research
describ
clinic
characterist
attempt
recogn
featur
infect
aircraft
sinc
earli
outbreak
china
strict
precautionari
measur
implement
especi
zhejiang
provinci
govern
initi
launch
categori
respons
respons
major
public
health
emerg
morn
th
januari
one
day
commerci
aircraft
carri
passeng
crew
member
flew
hangzhou
intern
airport
zhejiang
passeng
chines
tourist
return
home
board
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
work
group
singapor
airport
implement
strict
preflight
screen
find
whether
fever
respiratori
symptom
none
symptomat
passeng
taken
precautionari
measur
possibl
exposur
flight
attend
well
wore
mask
flight
man
passeng
patient
travel
wuhan
fever
respiratori
symptom
also
wear
mask
flight
plane
arriv
hangzhou
pm
consid
wuhan
citizen
aircraft
staff
hangzhou
center
diseas
control
prevent
cdc
standbi
airport
aircraft
arriv
board
screen
possibl
fever
respiratori
symptom
amongst
passeng
crew
member
found
patient
still
fever
temperatur
throat
swab
specimen
collect
sent
cdc
five
hour
later
confirm
posit
admit
design
hospit
crew
member
rest
passeng
place
isol
routin
medic
check
hotel
near
airport
day
observ
whether
ill
onset
happen
shown
figur
nine
passeng
success
test
posit
also
admit
anoth
two
passeng
also
test
posit
fail
interview
patient
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
found
two
week
isol
among
remain
passeng
crew
member
releas
quarantin
conduct
retrospect
studi
focus
clinic
characterist
ten
patient
success
admit
xiaoshan
first
peopl
hospit
flight
patient
diagnos
base
nation
health
commiss
peopl
republ
china
guidelin
interim
guidanc
ten
patient
includ
studi
recogn
exposur
histori
day
fight
incub
period
defin
time
flight
arriv
day
onset
ill
hospit
day
defin
period
admiss
discharg
day
studi
review
approv
medic
ethic
committe
xiaoshan
first
peopl
hospit
approv
written
inform
consent
waiv
urgent
need
collect
clinic
data
emerg
diseas
entir
anonym
data
therefor
individu
ident
identifi
epidemiolog
data
collect
interview
patient
includ
exposur
histori
date
ill
onset
hospit
admiss
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
discharg
clinic
inform
includ
symptom
chest
ct
imag
therapi
hospit
stay
laboratori
result
admiss
retrospect
collect
medic
record
two
experienc
radiologist
fu
x
jian
review
chest
ct
imag
positiveneg
find
radiolog
featur
decid
consensu
epidemiolog
data
clinic
inform
sent
two
experienc
physician
g
qian
n
yang
inform
unclear
miss
clarifi
detail
attend
doctor
treat
patient
throat
swab
specimen
collect
patient
sent
cdc
test
rna
rtpcr
use
establish
set
primer
outcom
readi
three
hour
laboratori
confirm
achiev
result
rtpcr
posit
laboratori
test
conduct
day
admiss
includ
blood
cell
count
creactiv
protein
procalcitonin
serum
chemistri
ddimer
fibrinogen
coagul
test
liver
renal
function
electrolyt
lactat
dehydrogenas
five
lung
lobe
assess
degre
involv
classifi
none
score
minim
score
mild
score
moder
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
score
sever
score
overal
lung
total
sever
score
reach
sum
five
lobe
score
rang
possibl
score
patient
receiv
antivir
treatment
arbidol
twice
daili
ten
patient
either
combin
lopinavirritonavir
twice
daili
seven
patient
darunavircobicistat
daili
three
patient
patient
treat
corticosteroid
rest
respiratori
rate
per
minut
multipl
pulmonari
lobe
show
progress
diseas
chest
ct
imag
two
day
oxygen
support
via
nasal
cannula
given
oxygen
satur
without
oxygen
support
patient
discharg
hospit
result
two
rtpcr
test
taken
hour
apart
neg
symptom
improv
obvious
accord
china
guidelin
mulbsta
score
assess
record
attend
physician
base
six
index
summar
continu
variabl
median
interquartil
rang
iqr
categor
variabl
present
count
percentag
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
categori
analys
conduct
ibm
spss
statist
softwar
version
th
februari
clinic
data
collect
ten
patient
laboratoryconfirm
flight
attend
infect
day
prior
flight
one
includ
patient
expos
confirm
suspect
patient
shown
tabl
median
incub
period
iqr
rang
longer
day
ill
onset
hospit
admiss
iqr
rang
day
median
age
iqr
rang
femal
none
pregnant
none
health
worker
ten
patient
two
patient
patient
asymptomat
neg
chest
ct
scan
throughout
diseas
cours
eight
patient
common
symptom
fever
patient
among
patient
temperatur
patient
symptom
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
includ
cough
headach
expector
wherea
sore
throat
anorexia
myalgia
seen
patient
tabl
show
laboratori
find
admiss
elev
creactiv
protein
seen
patient
leucopenia
white
blood
cell
count
l
lymphopenia
lymphocyt
count
l
observ
patient
respect
decreas
platelet
level
l
detect
patient
procalcitonin
level
within
normal
rang
less
patient
increas
level
aspart
aminotransferas
decreas
level
potassium
increas
level
ddimer
document
patient
two
patient
slight
increas
level
fibrinogen
normal
rang
shown
tabl
two
ten
patient
pneumonia
throughout
diseas
cours
typic
ct
find
pulmonari
parenchym
groundglass
opac
especi
peripher
lung
distribut
seen
patient
among
bilater
lung
involv
seen
patient
unilater
left
lung
involv
seen
patient
frequent
involv
lobe
left
lower
lobe
patient
right
lower
lobe
patient
patient
ct
imag
bilater
pulmonari
parenchym
groundglass
opac
consolid
also
seen
patient
notabl
crazypav
pattern
pleural
effus
figur
groundglass
nodul
also
seen
patient
median
number
lobe
lung
opac
involv
iqr
rang
median
lung
total
sever
score
iqr
rang
admiss
initi
rtpcr
admiss
posit
patient
howev
initi
chest
ct
posit
half
ten
patient
patient
neg
initi
rtpct
result
posit
third
time
week
follow
ill
onset
patient
receiv
antivir
treatment
receiv
arbidol
lopinavir
ritonavir
administ
patient
alongsid
darunavir
cobicistat
patient
alongsid
oseltamivir
patient
four
patient
given
empir
antibiot
treatment
patient
given
systemat
corticosteroid
treatment
patient
given
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
oxygen
support
via
nasal
cannula
five
patient
treat
tradit
chines
medicin
tcm
interferon
alpha
inhal
chloroquin
administ
patient
shown
tabl
none
patient
ever
admit
intens
care
unit
icu
moreov
patient
discharg
one
patient
still
isol
hospit
median
hospit
day
iqr
rang
discharg
patient
median
mulbsta
score
iqr
rang
estim
risk
aircraft
transmiss
calcul
number
person
diagnos
divid
total
number
person
flight
result
report
clinic
data
ten
passeng
laboratoryconfirm
flight
far
know
first
report
case
seri
inflight
transmiss
clinic
characterist
patient
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
transmiss
aircraft
similar
without
inflight
histori
previous
report
notabl
symptom
patient
infect
flight
rel
mild
outcom
inclin
better
risk
passeng
higher
compar
transmiss
sar
aircraft
imag
manifest
patient
transmiss
aircraft
similar
without
inflight
histori
previous
report
pleural
effus
rare
seen
amongst
patient
case
first
time
report
small
volum
pleural
effus
lung
nonsever
patient
moreov
patient
test
rtpcr
posit
admiss
patient
chest
ct
scan
posit
admiss
indic
rtpcr
higher
sensit
chest
ct
scan
diagnos
studi
patient
cohort
receiv
antivir
treatment
type
medicin
prescrib
vari
patient
base
condit
receiv
arbidol
use
lopinavir
combin
ritonavia
consid
benefici
potenti
treat
sar
rate
antibiot
corticosteroid
tcm
use
less
half
tcm
consid
play
crucial
role
treat
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
patient
china
especi
earli
mild
period
patient
treat
oxygen
support
nasal
cannula
oxygen
satur
without
oxygen
support
recov
current
wide
recogn
effect
drug
treatment
exist
date
result
random
control
studi
drug
patient
conduct
unclear
whether
improv
due
individu
drug
combin
ten
patient
risk
factor
known
associ
wors
outcom
comorbid
advanc
age
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
none
nine
flight
attend
symptomat
test
infect
although
interact
ill
passeng
flight
perhap
larg
use
mask
therefor
strongli
suggest
maskwear
hand
hygien
imper
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
measur
taken
passeng
flight
attend
pilot
measur
must
abid
board
flight
disembark
global
pandem
occur
studi
limit
retrospect
method
sampl
size
sever
issu
taken
consider
read
result
firstli
tri
obtain
passeng
roster
seat
assign
contact
inform
flight
scoot
airlin
singapor
well
health
commiss
cdc
hangzhou
fail
therefor
could
confirm
whether
transmiss
amongst
passeng
occur
board
featur
patient
randomli
distribut
throughout
aircraft
board
aircraft
featur
cluster
patient
seat
row
within
two
row
front
behind
index
patient
work
definit
contact
flight
passeng
seat
row
seat
within
two
seat
front
behind
index
patient
flight
attend
secondli
two
asymptomat
patient
report
studi
agre
asymptomat
carrier
might
found
passeng
crew
member
test
rtpcr
assay
releas
quarantin
report
presymptomat
symptomat
patient
equal
effect
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
spread
possibl
explan
aircraft
transmiss
presymptomat
asymptomat
flight
attend
mediat
transmiss
passeng
although
believ
less
like
flight
attend
wear
mask
thirdli
inform
physic
proxim
index
patient
unavail
therefor
could
quantifi
exact
risk
inflight
transmiss
especi
whether
degre
ill
passeng
consist
physic
proxim
index
patient
address
anecdot
report
outbreak
potenti
transmiss
airplan
although
symptom
mild
passeng
attend
must
protect
flight
systemat
investig
data
urgent
need
confirm
real
risk
exact
pattern
inflight
transmiss
clinic
characterist
outcom
patient
infect
flight
author
studi
declar
conflict
interest
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
authorfund
grant
medrxiv
licens
display
preprint
perpetu
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
p
e
n
p
e
n
p
e
n
p
e
n
p
e
n
p
e
n
p
e
n
p
e
n
p
e
n
p
e
n
n
r
e
n
q
r
c
h
e
c
n
r
p
c
r
q
u
n
v
e
r
p
c
r
p
n
l
c
h
e
c
g
n
g
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
http
doi
medrxiv
preprint
